Published in Breast Cancer Res Treat on February 13, 2010
Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance. Cancer Res (2011) 1.34
Resveratrol induces p53-independent, X-linked inhibitor of apoptosis protein (XIAP)-mediated Bax protein oligomerization on mitochondria to initiate cytochrome c release and caspase activation. J Biol Chem (2011) 1.14
Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo. Am J Cancer Res (2015) 0.94
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol (2012) 0.91
Sildenafil ameliorates biomarkers of genotoxicity in an experimental model of spontaneous atherosclerosis. Lipids Health Dis (2013) 0.83
Roles of sildenafil in enhancing drug sensitivity in cancer. Cancer Res (2011) 0.83
Level of macroautophagy drives senescent keratinocytes into cell death or neoplastic evasion. Cell Death Dis (2014) 0.81
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection. Heart Fail Rev (2015) 0.79
Repurposing phosphodiesterase-5 inhibitors as chemoadjuvants. Front Pharmacol (2013) 0.75
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27. J Clin Oncol (2008) 6.31
Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27. J Clin Oncol (2012) 4.33
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. Lancet Oncol (2013) 2.59
Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol (2005) 2.17
Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol (2009) 2.14
A comprehensive glossary of autophagy-related molecules and processes. Autophagy (2010) 2.00
A signature of immune function genes associated with recurrence-free survival in breast cancer patients. Breast Cancer Res Treat (2011) 1.99
Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies. Clin Infect Dis (2005) 1.87
Ineffective triggering predicts increased duration of mechanical ventilation. Crit Care Med (2009) 1.78
Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction. J Biol Chem (2002) 1.62
GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells. Breast Cancer Res Treat (2009) 1.60
Radiosensitization of MDA-MB-231 breast tumor cells by adenovirus-mediated overexpression of a fragment of the XRCC4 protein. Mol Cancer Ther (2005) 1.59
Short course of omeprazole: a better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol (2002) 1.58
Prestroke modified rankin stroke scale has moderate interobserver reliability and validity in an acute stroke setting. Stroke (2012) 1.49
Additivity of pyrethroid actions on sodium influx in cerebrocortical neurons in primary culture. Environ Health Perspect (2011) 1.45
Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference. J Clin Oncol (2008) 1.42
Accelerated partial-breast irradiation: trial by media or by science? Int J Radiat Oncol Biol Phys (2012) 1.41
Breast conservation therapy rates are no different in medically indigent versus insured patients with early stage breast cancer. J Surg Oncol (2003) 1.39
Aerobic exercise alters postprandial lipemia in African American versus White women. Int J Sport Nutr Exerc Metab (2008) 1.39
Signatures associated with rejection or recurrence in HER-2/neu-positive mammary tumors. Cancer Res (2008) 1.38
Thyroid-hormone-disrupting chemicals: evidence for dose-dependent additivity or synergism. Environ Health Perspect (2005) 1.35
Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells. Cancer Immunol Immunother (2008) 1.30
Human T cells express CD25 and Foxp3 upon activation and exhibit effector/memory phenotypes without any regulatory/suppressor function. J Transl Med (2009) 1.26
Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy? J Pharmacol Exp Ther (2013) 1.24
Docking and hydropathic scoring of polysubstituted pyrrole compounds with antitubulin activity. Bioorg Med Chem (2007) 1.18
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden. Surgery (2013) 1.16
Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison. Toxicol Appl Pharmacol (2006) 1.16
Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol (2012) 1.15
Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine. Eur J Pharmacol (2005) 1.13
Evasion of a single-step, chemotherapy-induced senescence in breast cancer cells: implications for treatment response. Clin Cancer Res (2005) 1.13
Effects of surgical excision on survival of patients with stage IV breast cancer. J Surg Res (2009) 1.10
Dual functions of autophagy in the response of breast tumor cells to radiation: cytoprotective autophagy with radiation alone and cytotoxic autophagy in radiosensitization by vitamin D 3. Autophagy (2012) 1.07
Why do we pay? A national survey of investigators and IRB chairpersons. J Empir Res Hum Res Ethics (2010) 1.07
Changing trends in phthalate exposures. Environ Health Perspect (2014) 1.06
Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients. Crit Care (2008) 1.05
Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys (2003) 1.05
The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res (2003) 1.04
Apoptosis, autophagy, accelerated senescence and reactive oxygen in the response of human breast tumor cells to adriamycin. Biochem Pharmacol (2009) 1.04
IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo. Breast Cancer Res Treat (2009) 1.03
Insurance and inpatient care: differences in length of stay and costs between surgically treated cancer patients. Cancer (2012) 1.03
Potentiation of radiation sensitivity in breast tumor cells by the vitamin D3 analogue, EB 1089, through promotion of autophagy and interference with proliferative recovery. Mol Cancer Ther (2006) 1.03
The autophagy-senescence connection in chemotherapy: must tumor cells (self) eat before they sleep? J Pharmacol Exp Ther (2012) 1.03
Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients. J Transl Med (2013) 1.03
Autophagic cell death, polyploidy and senescence induced in breast tumor cells by the substituted pyrrole JG-03-14, a novel microtubule poison. Biochem Pharmacol (2007) 1.02
Alcohol use disorders increase the risk for mechanical ventilation in medical patients. Alcohol Clin Exp Res (2007) 1.02
A switch between cytoprotective and cytotoxic autophagy in the radiosensitization of breast tumor cells by chloroquine and vitamin D. Horm Cancer (2011) 1.01
Analysis of Environmental Chemical Mixtures and Non-Hodgkin Lymphoma Risk in the NCI-SEER NHL Study. Environ Health Perspect (2015) 1.00
An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells. J Neurosurg (2006) 0.98
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis. Breast Cancer Res Treat (2008) 0.98
Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model. Cancer Immunol Immunother (2003) 0.97
A gene transcription signature of obesity in breast cancer. Breast Cancer Res Treat (2011) 0.96
Support of science-based decisions concerning the evaluation of the toxicology of mixtures: a new beginning. Regul Toxicol Pharmacol (2002) 0.96
Bevacizumab and breast cancer: what does the future hold? Future Oncol (2012) 0.92
Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells. Breast Cancer Res Treat (2013) 0.92
Imaging multidrug resistance with 4-[18F]fluoropaclitaxel. Nucl Med Biol (2007) 0.92
Interference with endothelial cell function by JG-03-14, an agent that binds to the colchicine site on microtubules. Biochem Pharmacol (2009) 0.92
Clinical and pathologic features of cynomolgus macaques (Macaca fascicularis) infected with aerosolized Yersinia pestis. Comp Med (2008) 0.92
Autophagy, cell death and sustained senescence arrest in B16/F10 melanoma cells and HCT-116 colon carcinoma cells in response to the novel microtubule poison, JG-03-14. Cancer Chemother Pharmacol (2012) 0.91
Physiological effects of enteral and parenteral feeding on pancreaticobiliary secretion in humans. Am J Physiol Gastrointest Liver Physiol (2003) 0.91
Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes. Int Immunol (2004) 0.89
Toxicity issues in cancer drug development. Curr Opin Investig Drugs (2010) 0.89
What Can Epidemiological Studies Tell Us about the Impact of Chemical Mixtures on Human Health? Environ Health Perspect (2016) 0.89
Cytotoxicity, DNA strand breakage and DNA-protein crosslinking by a novel transplatinum compound in human A2780 ovarian and MCF-7 breast carcinoma cells. Biochem Pharmacol (2004) 0.89
Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions. Surg Clin North Am (2003) 0.88
Neurotoxicological interactions of a five-pesticide mixture in preweanling rats. Toxicol Sci (2006) 0.88
Phthalate treatment does not influence levels of IgE or Th2 cytokines in B6C3F1 mice. Toxicology (2004) 0.88
A novel cytostatic form of autophagy in sensitization of non-small cell lung cancer cells to radiation by vitamin D and the vitamin D analog, EB 1089. Autophagy (2014) 0.88
Anibamine, a natural product CCR5 antagonist, as a novel lead for the development of anti-prostate cancer agents. Bioorg Med Chem Lett (2010) 0.87
Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells. Mol Cancer Res (2011) 0.87
The sheep erythrocyte T-dependent antibody response (TDAR). Methods Mol Biol (2010) 0.87
Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure. J Transl Med (2011) 0.87
Multiple classes of environmental chemicals are associated with liver disease: NHANES 2003-2004. Int J Hyg Environ Health (2013) 0.87
Myeloid-derived suppressor cells enhance IgE-mediated mast cell responses. J Leukoc Biol (2013) 0.86
Drinking water exposure to cadmium, an environmental contaminant, results in the exacerbation of autoimmune disease in the murine model. Toxicology (2003) 0.86
Comparative cardiac toxicity of anthracyclines in vitro and in vivo in the mouse. PLoS One (2013) 0.86
Response-surface modeling of the effect of 5alpha-dihydrotestosterone and androgen receptor levels on the response to the androgen antagonist vinclozolin. Toxicol Sci (2002) 0.86
Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma. BMC Immunol (2010) 0.85
Interlaboratory study of the primary antibody response to sheep red blood cells in outbred rodents following exposure to cyclophosphamide or dexamethasone. J Immunotoxicol (2007) 0.85
A mouse model of radiation-induced cardiomyopathy. Int J Cardiol (2012) 0.85
Influence of p53 and caspase 3 activity on cell death and senescence in response to methotrexate in the breast tumor cell. Biochem Pharmacol (2004) 0.84
Resistance exercise and postprandial lipemia: The dose effect of differing volumes of acute resistance exercise bouts. Metabolism (2005) 0.84
The moderating role of sensory Overresponsivity in HPA activity: a pilot study with children diagnosed with ADHD. J Atten Disord (2009) 0.84
Evidence for dose-additive effects of pyrethroids on motor activity in rats. Environ Health Perspect (2009) 0.84
Photocaged permeability: a new strategy for controlled drug release. Chem Commun (Camb) (2012) 0.84
Who's doing the math? Are we really compensating research participants? J Empir Res Hum Res Ethics (2010) 0.83
Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response. Mamm Genome (2008) 0.83
Component-based and whole-mixture techniques for addressing the toxicity of drinking-water disinfection by-product mixtures. J Toxicol Environ Health A (2004) 0.82
Differential STAT5 activation and phenotypic marker expression by immune cells following low levels of ethanol consumption in mice. Immunopharmacol Immunotoxicol (2002) 0.82
R = 20: bias in the reporting of respiratory rates. Am J Emerg Med (2008) 0.81
Novel insights on the effect of nicotine in a murine colitis model. J Pharmacol Exp Ther (2012) 0.81
Establishment and comparison of delayed-type hypersensitivity models in the B₆C₃F₁ mouse. J Immunotoxicol (2010) 0.81
Ex vivo expansion of tumor-reactive T cells by means of bryostatin 1/ionomycin and the common gamma chain cytokines formulation. J Vis Exp (2011) 0.81
Potentiation of cell killing by fractionated radiation and suppression of proliferative recovery in MCF-7 breast tumor cells by the Vitamin D3 analog EB 1089. J Steroid Biochem Mol Biol (2004) 0.81
Combined antiproliferative effects of the aminoalkylindole WIN55,212-2 and radiation in breast cancer cells. J Pharmacol Exp Ther (2013) 0.80